Skip to main content
. 2016 Jan 14;22(2):862–873. doi: 10.3748/wjg.v22.i2.862

Table 1.

Hepatitis C virus proteins, their function, role in immune response and position in different hepatitis C virus vaccines

HCV proteins Genetic stability Function Role in immune responses HCV vaccines
Structural proteins
Core (C): P22 Stable Major component of viral nucleocapsid Target for neutralizing Ab and CMI Synthetic peptides vaccines; e.g., VAL-44 in mice[66]
Binds viral RNA during assembly Block the innate immune response Recombinant yeast cells (GI-5005) that produce an HCV NS3-Core fusion protein in mice[70]
DNA vaccine: CIGB-230 in humans[100]
E1: gp 35 envelope glycoproteins High degree of genetic diversity Receptor binding and HCV entry into target cells Target for nAbs The primary immunogen for vaccinology[8,78]
E2: gp 70 envelope glycoproteins Continuous variation allowing viral escape of HCV specific CD8 T cells and nAb and exhaustion of CD8 cell in chronic HCV infection[101] Recombinant HCV E1E2 glycoproteins in chimpanzees/humans -core/E1/E2 (CIGB-230) in human[13,96,100]
Target for pan-genotypic drug therapy Fusion proteins containing the entire HCV E1 or E2 sequence that is efficiently co-assembled with the HBV S into particles[82]
E1E2MF59 HCV DNA vaccine in human[8]
Non-structural proteins
NS1: p7 small polypeptide Stable Ion channel localized to plasma membrane No assigned role -
NS2: p23 Protease transmembrane protein NS2/3 cleavage is required for persistent viral infection in chimpanzees Full-length HCV NS2 protein DNA vaccine in mice[102]
HCV Proteins Genetic stability Function Role in immune responses HCV vaccines
NS3: p70 Bifunctional serine protease and RNA helicase Act as a critical immune regulator during HCV infection[102] Recombinant yeast cells (GI-5005) that produce an HCV NS3-Core fusion protein in mice[70]
NS4A: p8 Stable Protease cofactor Block the innate immune response[103] Ad vector vaccine ( NS3-NS5B in chimpanzees/humans[25,87]
DNA vaccine: e.g.,
Chron Vac-c in mice with multiple epitopes; NS3/4a, NS4b, NS5a, and NS5b in Rhesus macaques[84]
ChronVac-C- NS3/4A-expressing DNA vaccine in human in human[73]
DNA plasmid vaccine encoding NS3/4a, NS4b, NS5a, and NS5b in Rhesus macaques[28]
NS4B: p27 Stable Proteins Block the innate immune response[103] Synthetic peptides vaccines; e.g., VAL-44[66]
Components of the viral replicase complex DNA vaccine with multiple epitopes; NS3/4a, NS4b, NS5a, and NS5b in Rhesus macaques[28]
NS5A:p56/58 Stable Cofactor for NS5B Block the innate immune response[103] In mice: Synthetic peptides vaccines; e.g., VAL-44[67]-NS5a-loaded DCs[89]
Regulate response to INF-α treatment Modulate the cellular environment to favor virus replication and persistence[104]
Protects cells from TNF-α-mediated apoptotic death[104] in Rhesus macaques: DNA vaccine with multiple epitopes; NS3/4a, NS4b, NS5a, and NS5b[28]
NS5B: p68 Stable RNA dependent polymerase No assigned role DNA vaccine with multiple epitopes; NS3/4a, NS4b, NS5a, and NS5b in Rhesus macaques[28]
Ad vector vaccine (NS3-NS5B in chimpanzees/humans)[97]

HCV: Hepatitis C virus.